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Abstract
Background:  The  prosthetic  joint  infection  is  the  most  feared  and  catastrophic  complication
for cause  severe  physical  damage  to  patients  and,  generates  high  economic  costs.
Objectives:  To  describe  the  microbiological  characteristics  and  to  determine  the  resistance
pattern in  prosthetic  joint  infections  in  a  reference  hospital  in  Mexico.
Material  and  methods:  Patients  whose  prosthetic  devices  were  withdrawn  due  to  suspicion  of
septic and  aseptic  loosening  were  included.  Cultures  were  performed  to  identify  microorganisms
and susceptibility  analysis.
Results:  Of  the  111  patients  included,  55%  were  diagnosed  with  prosthetic  joint  infection,
with the  most  frequent  prosthesis  being  of  the  hip  (43%).  Positive  cultures  were  obtained
in 97%  of  the  infected  cases,  of  which  75%  were  monomicrobial  infections.  The  most  fre-
quent bacterial  species  isolated  were:  Staphylococcus  epidermidis  (31%),  Enterococcus  faecalis
(16%), Staphylococcus  aureus  (13%),  and  Escherichia  coli  (8%).  The  resistance  patterns  for  the
Staphylococcus  genus  were:  oxacillin  (79%),  erythromycin  (45%)  and  ciproﬂoxacin  (37%).  Entero-
coccus faecalis  showed  a  high  percentage  of  resistance  to  erythromycin  and  clindamycin  (86%),
and ﬂuoroquinolones  (43%).  The  large  majority  (86%)  of  Escherichia  coli  were  extended  spec-
trum beta-lactamases  positive,  in  addition  to  having  high  resistance  to  ﬂuoroquinolones  (86%),
trimethoprim/sulfamethoxazole  (86%)  and  gentamicin  (72%).
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Conclusion:  The  microbiological  characteristics  found  in  prosthetic  joint  infections  vary  accord-
ing to  the  hospitals.  In  this  series,  a  high  proportion  of  coagulase-negative  Staphylococci  and
Enterococcus  spp.  were  found,  as  well  as  a  high  bacterial  resistance.
© 2015  Academia  Mexicana  de  Cirugía  A.C.  Published  by  Masson  Doyma  México  S.A.  This  is
an open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/
by-nc-nd/4.0/).
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Características  microbiológicas  y  patrones  de  resistencia  en  infecciones  de  prótesis
articular  en  un  hospital  de  referencia
Resumen
Antecedentes:  La  infección  de  prótesis  articular  es  la  complicación  más  temida  y  catastróﬁca,
por causar  severos  dan˜os  físicos  en  los  pacientes,  y  generar  elevados  costos  económicos.
Objetivos:  Describir  las  características  microbiológicas  y  determinar  los  patrones  de  resistencia
que se  presentan  en  infecciones  de  prótesis  articular  en  un  hospital  de  referencia  en  México.
Material y  métodos:  Se  incluyeron  pacientes  a  los  que  se  les  retiró  la  prótesis  articular  por
sospecha de  aﬂojamiento  aséptico  y  séptico.  Se  hizo  búsqueda  microbiológica  y  análisis  de
susceptibilidad.
Resultados:  Se  incluyeron  111  pacientes,  el  55%  se  diagnosticaron  con  infección  de  prótesis
articular,  siendo  la  más  frecuente  la  prótesis  de  cadera  (43%).  En  el  97%  de  los  casos  infectados
se tuvieron  cultivos  positivos,  el  75%  fueron  infecciones  monomicrobianas.  Las  especies  bacte-
rianas aisladas  con  mayor  frecuencia  fueron:  Staphylococcus  epidermidis  (31%),  Enterococcus
faecalis (16%),  Staphylococcus  aureus  (13%)  y  Escherichia  coli  (8%).  El  patrón  de  resistencia
en las  2  primeras  fue:  oxacilina  (79%),  eritromicina  (45%)  y,  ciproﬂoxacino  (37%).  Enterococcus
faecalis mostró  alto  porcentaje  de  resistencia  para:  eritromicina  y  clindamicina  (86%),  y  ﬂuoro-
quinolonas  (43%).  El  86%  de  las  Escherichia  coli  tenían  betalactamasas  de  espectro  extendido,
además de  alta  resistencia  para  ﬂuoroquinolonas  (86%),  trimetoprim/sulfametoxazol  (86%)  y
gentamicina  (72%).
Conclusión:  Las  características  microbiológicas  encontradas  en  infecciones  de  prótesis  artic-
ular varía  de  acuerdo  a  los  centros  hospitalarios;  en  esta  serie  se  encontró  una  proporción
alta de  Staphylococcus  coagulasa  negativos  y  Enterococcus  spp.,  así  como  una  alta  resistencia
bacteriana.
© 2015  Academia  Mexicana  de  Cirugía  A.C.  Publicado  por  Masson  Doyma  México  S.A.  Este  es
un artículo  Open  Access  bajo  la  licencia  CC  BY-NC-ND  (http://creativecommons.org/licenses/
by-nc-nd/4.0/).
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oackground
he  implantation  of  prosthetic  joints  is  a  therapeutic  option
sed  to  improve  the  mobility  and  quality  of  life  of  those
atients  who  suffer  from  joint  wear  and  tear1;  however,
n  a  small  number  of  cases,  ﬁtting  the  prosthetic  material
ay  lead  to  complications  which  affect  the  patient  and  the
urgical  outcome.  The  most  common  complications  asso-
iated  with  arthoplasties  are  the  aseptic  loosening  of  the
oint  and  prosthetic  joint  infection  (PJI),  the  latter  being  the
ost  serious  catastrophic  occurrence  since  it  usually  causes
rreversible  physical  sequelae  with  high  economic  costs,  due
o  prolonged  administration  of  antimicrobial  treatments  and
onstant  hospital  stays.2,3
In  general  the  most  common  aetiological  agents  in  pros-
hetic  joint  infections  are  of  the  genus  Staphylococcus,
he  most  common  of  which  is  Staphylococcus  aureus  (S.
ureus)4;  however,  it  has  been  observed  that  distribution
hanges,  depending  on  geographical  location  or  hospital
entre.  For  example,  Bejon  et  al.5 described  how  in  the
r
s
I
trthopaedic  centre  in  Oxford,  United  Kingdom,  the  most  fre-
uent  species  were  of  the  negative  coagulase  Staphylococci.
here  are  therefore  differences  between  microorganism  dis-
ribution  and  also  between  the  patterns  of  antimicrobial
esistence.6,7
In  Mexico  up  to  the  present  day,  studies  published  on
rosthetic  joint  infections  do  not  offer  a  detailed  description
f  microbiological  characteristics  and  antimicrobial  resis-
ance  patterns8--10 and  it  is  thus  of  the  utmost  importance  to
ain  knowledge  of  the  microbial  epidemiology  and  antimi-
robial  susceptibility  of  this  type  of  infection  to  establish
reventative  guidelines  and  optimise  empirical  antimicro-
ial  treatments  to  use  in  the  prevention  of  infections  related
o  prosthetic  joints.
The  aim  of  this  study  was  to  describe  the  microbi-
logical  characteristics  and  determine  the  antimicrobial
esistance  patterns  in  prosthetic  joint  infections  which  pre-
ented  or  had  been  referred  to  the  National  Rehabilitation
nstitute  --  the  largest  Health  Department’s  referral  hospi-
al  in  Mexico  --  which  specialises  in  treating  musculoskeletal
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Figure  1  Diagnostic  percentage  in  the  cases  of  prosthetic
joint infection  or  aseptic  loosening,  depending  on  the  type  of
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pathologies  and  in  carrying  out  primary  and  revision  arthro-
plasties.
Materials and  methods
We  conducted  an  observational,  cross-sectional,  descriptive
study  from  20  November  2011  to  23  November  2013.  All
patients  who  had  had  a  prosthetic  joint  removed  due  to
aseptic  or  septic  loosening  were  included  in  the  study.  At
least  3  biopsies  of  periprosthetic  tissue  for  microbiological
examination  had  also  been  performed.
Deﬁnition  of  prosthetic  joint  infection
Prosthetic  joint  infection  was  deﬁned  according  to  when
patients  met  the  following  criteria:
1.  Two  positive  cultures  of  periprosthetic  tissue  or  a  posi-
tive  culture  of  the  prosthetic  joint,  with  phenotypically
identical  microorganisms.
2.  Formation  of  a  ﬁstula  in  the  prosthetic  joint.
3.  Meeting  3  of  the  following  lesser  criteria:  (a).  Ele-
vated  serum  C-reactive  protein  levels  and  globular
sedimentation  speed.  (b)  High  white  blood  cell  count  in
synovial  ﬂuid.  (c)  High  percentage  of  polymorphonuclear
neutrophils  in  synovial  liquid.  (d)  Positive  histologi-
cal  analysis  of  the  periprosthetic  tissue.  (e)  A  positive
culture.
Periprosthetic  tissue  culture
The  periprosthetic  tissues  were  prepared  for  transportation
and  immediately  taken  to  the  laboratory.  They  were  then
macerated  and  homogenised  in  2  ml  of  sterile  saline  solution
(0.85%).  Alliquots  of  0.1  ml  were  taken  from  the  macera-
tion  solution  and  plated  in  the  following  culture  mediums:
5%  sheep  blood  agar,  MacConkey  agar,  phenyl  alcohol  agar,
Sabouraud  agar  with  antibiotic  and  thioglycolate  broth.
Culture  conditions  and  times  used  were  as  follows:  aerobic
microorganisms:  37 ◦C,  7  days;  fungal  microorganisms:  room
temperature,  30  days:  anaerobic  microorganisms:  37 ◦C,  2
days.
Prosthetic  Joint  Culture
The  prosthetic  joint  culture  was  performed  using  the  son-
ication  technique  brieﬂy  described  by  Trampuz  et  al.4 The
prosthetic  joint  was  placed  in  a  sterile  polypropylene  recip-
ient.  400  ml  of  saline  solution  (0.85%)  was  then  added  to
the  recipient.  This  was  immediately  place  in  an  ultrasonic
cleaner  (BRANSON  3510,  U.S.A.)  at  40  kHz  for  5  min.  Once
the  time  was  up,  aliquots  of  0.1  ml  were  taken  from  the  son-
ication  liquid,  which  were  then  plated  and  cultivated  under
the  same  conditions  as  the  periprosthetic  tissues.
Identiﬁcation  and  microorganisms  susceptibility
trials
Developed  cultures  were  identiﬁed  and  susceptibility  test-
ing  took  place  with  the  semiautomatic  Vitek  2  (BioMériux,
w
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(rosthesis  (n  =  111);  data  are  presented  as  %.  AL:  aseptic  loos-
ning;  PJI:  prosthetic  joint  infection.
rance)  equipment,  in  accordance  with  the  manufacturer’s
ecommendations.
Descriptive  statistics  (average,  median  and  frequencies)
sing  Stata  12.0  software  was  used  for  data  analysis.
esults
he  study  included  111  patients  who  had  had  their  prosthe-
es  removed.  Seventy  ﬁve  (68%)  patients  were  female  and
he  median  age  was  64  (19--91).  The  following  types  of  pros-
hetic  joints  were  removed:  hip,  83  (75%);  knee,  27  (24%);
nd  elbow,  1  (1%).  An  average  of  3  periprosthetic  tissue  sam-
les  were  cultivated  for  each  patient  (ranging  from  3  to  6
amples).  Of  the  patients  included  62  (55%)  were  diagnosed
s  prosthetic  joint  infection,  the  hip  prosthesis  was  the  most
nfected  joint  (Fig.  1).
Positive  cultures  were  obtained  in  59  (97%)  patients  with
rosthetic  joint  infection;  the  3  remaining  patients  were
linically  diagnosed,  due  to  ﬁstula  presence.  Forty  four  (75%)
nfections  were  monomicrobial  and  15  (25%)  were  polymi-
robial.  Of  the  microorganisms  isolated,  70  (80%)  were
ram-positive,  14  (16%)  were  Gram-negative  and  3  (4%)
ere  fungal  microorganisms  (Table  1).  The  bacterial  species
solated  with  greater  frequency  were  ﬁrstly  Staphylococcus
pidermidis  (S.  epidermidis), followed  by  Enterococcus  fae-
alis  (E.  faecalis),  S.  aureus  and  Escherichia  coli  (E.  coli), at
7  (31%),  14  (16%),  11  (13%)  and  7  (8%),  respectively.  In  the
olymicrobial  PJI,  the  average  of  isolated  microorganisms
as  3  species  (ranging  from  2  to  4  species).  Fig.  2  describes
he  microbiological  characteristics  of  this  type  of  infection.
Table  2  shows  the  percentage  of  resistance  to  diverse
ntibiotics,  in  the  4  species  of  microorganisms  which  were
solated  with  greater  frequency.  A  high  antimicrobial  resis-
ance  to  oxacillin  (79%),  erythromycin  (45%),  ciproﬂoxacin
37%)  and  clindamycin  (32%)  was  found  in  S.  epidermidis
nd  S.  aureus.  E.  faecalis  showed  resistance  to  erythro-
ycin  (86%),  clindamycin  (86%),  ciproﬂoxacin  (43%)  and
evoﬂoxacin  (43%).  None  of  the  Gram-positive  cocci  were
esistant  to  vancomycin.  86%  of  the  isolated  E.  coli  strains
ere  positive  broad  spectrum  beta  lactamases;  they  also
resented  resistance  to  ciproﬂoxacin  (86%),  levoﬂoxacin
86%),  trimetoprim/sulfamethoxazole  (86%)  and  gentamicin
71%).
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Table  1  Distribution  of  microorganisms  isolated  in  positive
cultures.
Microorganism  n  (%)
Gram-positive  70  (80)
Staphylococcus  spp.
S.  epidermidis  27  (31)
S. aureus  11  (13)
S. hominis  5  (6)
S. lugdunensis  1  (1)
S. caprae 1  (1)
S. sciuri 1  (1)
S. lentus 1  (1)
Enterococcus  spp.
E.  faecalis  14  (16)
E. faecium  1  (1)
E. casseliﬂavus  1  (1)
Streptococcus  spp.
St.  anginosus 2  (2)
St. salivarius 1  (1)
St. agalactiae 1  (1)
Others
Gemella  sp.  1  (1)
Corynebacterium  striatum  1  (1)
Parvimonas  micra  1  (1)
Gram-negative  14  (16)
Enterobacteriaceae
Escherichia  coli  7  (8)
Salmonella  spp.  1  (1)
Klebsiella  pneumoniae  1  (1)
Pantoea  agglomerans  1  (1)
NGFGRB
Acinetobacter  baumannii 2  (2)
Pseudomonas  ﬂourescens 2  (2)
Fungi 3  (4)
Candida  lipolytica  1  (1)
Candida  parapsilosis  1  (1)
Rhodotorula  mucilaginosa  1  (1)
NGFGRB: non-glucose fermenters Gram-negative bacilli.
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Table  2  Resistance  pattern  to  different  antibiotics  of  the  4  micr
OXA  AMP  CRO  CAZ  FEP  AZT  IMP  ETP  
S.  epidermidis
(n  =  27)
66%  --  --  --  --  --  --  --  
S. aureus
(n  =  11)
13%  --  --  --  --  
Total (n  =  38)  79%  --  --  --  --  --  --  --  
E. faecalis
(n  =  14)
--  21%  --  --  --  --  --  --  
E. coli  (n  =  7)  --  86%  86%  86%  86%  86%  0%  0%  
AK: amikacin; AMP: ampicillin; AZT: aztreonam; CAZ: ceftazidime; C
romycin; ETP: ertapenem; FEP: cefepime; GM: gentamicin; IMP: imip
rifampicin; SXT: trimethoprim/sulfamethoxazole; VA: vancomycin.
The global results of sensitivity to the Staphylococcus (S. epidermidis oint infections.  PJI:  prosthetic  joint  infection;  NGFGRB:  non-
lucose fermenters  Gram-negative  bacilli.
iscussion
ver  the  last  few  decades  joint  replacement  has  become
ne  of  the  most  frequent  surgical  procedures  in  industri-
lised  countries.11 This  surgery  improves  the  mobility  and
uality  of  life  of  patients  suffering  from  joint  wear  and  tear;
owever,  several  cases  present  complications  which  may
ffect  patient  and  surgical  outcome.  Aseptic  loosening  and
nfection  are  among  the  most  common  complications  which
sually  present  after  a joint  replacement  procedure.12 In  a
tudy  published  by  Zhang  et  al.13 the  authors  state  that  out
f  10,000  hip  and  knee  replacements  performed  in  Australia
n  2013,  13%  were  revision  arthroplasties  caused  by  problems
ith  the  prosthetic  joint  and  of  these,  29%  were  due  to  asep-
ic  loosenings  and  20%  to  prosthetic  joint  infection.  Allepuz
t  al.1 calculated  that  of  the  6027  revision  arthroplasty
eplacements  performed  in  2  referral  hospitals  in  Spain  in
 year,  13%  were  caused  by  aseptic  loosening  and  17%  by
rosthetic  joint  infection.  The  number  of  aseptic  loosen-
ngs  and  prosthetic  joint  infection  we  found  were  much
igher  than  the  above-mentioned  ﬁgures,  with  the  latter
eing  the  most  frequent,  since  a  little  over  half  of  patients
hose  prosthetic  joint  was  removed  presented  with  infec-
ion.  Prosthetic  joint  infection  is  one  of  the  most  serious  and
atastrophic  complications,  because  in  the  majority  of  cases
here  are  usually  irreversible  physical  scars;  treatment  also
enerates  high  economic  costs  to  the  health  system.14
oorganisms  isolated  with  greater  frequency.
MRP  CIP  LVX  AK  GM  E  CLI  VA  RIF  SXT
--  24%  16%  --  --  29%  16%  0%  10%  26%
--  13%  13%  --  --  16%  16%  8%  0%
--  37%  29%  --  --  45%  32%  0%  18%  26%
--  43%  43%  --  --  86%  86%  0%  --  --
0%  86%  86%  14%  71%  --  --  --  --  86%
IP: ciproﬂoxacin; CLI: clindamycin; CRO: ceftriaxone; E: eryth-
enem; LVX: levoﬂoxacin; MRP: meropenem; OXA: oxacillin; RIF:
and S. aureus)  are in bold.
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The  most  common  causes  of  the  development  of  PJIs
are  direct  contamination  of  the  prosthetic  material  during
surgery  caused  by:  skin  bacteria  from  medical  personnel  or
the  patient  him/herself;  by  haematogenous  dissemination
when  the  bacteria  comes  from  a  different  place  in  the  body
and  through  loss  of  continuity  in  the  skin  or  when  there  are
infectious  processes  in  the  surrounding  soft  tissues  of  the
prosthetic  joint.15,16
The  main  microorganisms  which  cause  this  type  of  infec-
tion  are  reported  to  be:  ﬁrstly  Gram  positive  cocci  (70%),
followed  by  Gram-negative  bacilli  (20%)  and  under  1%  of
fungal  microorganisms.17,18 Of  the  ﬁrst  group,  the  most  fre-
quent  species  are:  S.  aureus  (45%),  S.  epidermidis  (36%)  and
Enterococcus  spp.  (10%).19,20 In  this  study  similar  percent-
ages  of  Gram-positive  cocci  were  isolated,  but  by  species
we  observed  that  S.  epidermidis  and  Enterococcus  spp.
were  the  most  frequent;  the  latter  were  even  higher  in
number  than  the  S.  aureus, which  is  one  of  the  most
important  microorganisms  in  prosthetic  joint  infection21.
The  Enterococcus  spp.  species  cause  several  types  of  infec-
tions,  mainly  nosocomial  infections,  endocarditis,  urinary
tract  infections  and  intra-abdominal  and  pelvic  infections.22
Although  it  is  not  a  frequent  pathogen  for  orthopaedic  infec-
tions,  there  is  a  large  number  of  reports  which  show  an
increase  in  orthopaedic  infections  caused  by  Enterococcus
spp.23 Tornero  et  al.24 conducted  a  multicentric  study  to
describe  the  clinical  and  microbiological  characteristics  of
prosthetic  joint  infection  by  Enterococcus  spp.  The  study
shows  that  approximately  9.3%  of  prosthetic  joint  infection
are  caused  by  these  microorganisms,  with  E.  faecalis  and
Enterococcus  faecium  being  the  species  which  are  most  iso-
lated,  mainly  in  polymicrobial  polymicrobial  prosthetic  joint
infection.  As  previously  mentioned,  we  found  a  large  number
of  prosthetic  joint  infection  were  caused  by  Enterococcus
spp.  and  the  species  we  isolated  the  most  were  the  same  as
those  reported  by  Tornero  et  al.,  in  addition  to  polymicrobial
infections  having  been  isolated  (69%).  In  the  polymicrobial
prosthetic  joint  infection  by  Enterococcus  spp.,  we  observed
that  these  microorganisms  were  together  with:  Staphylococ-
cus  spp.,  Enterobacteriacea  and  Pseudomonas  aeruginosa
(P.  aeruginosa). Another  characteristic  observed  was  that
the  Enterococcus  spp.  were  isolated  mainly  in  prosthetic  hip
joints  (81%).  This  may  be  associated  with  poor  pre-surgical
hygiene  or  proximity  to  the  genital  area.
Regarding  Gram-negative  bacilli  in  prosthetic  joint  infec-
tion,  epidemiologic  studies  such  as  that  of  Rodríguez  Pardo
and  his  workgroup25 describe  that  the  most  frequent  causes
of  this  type  of  infections  are:  Enterobacteriaceae  (78%),
P.  aeruginosa  (20%)  and  other  Gram-negative  bacilli  (2%).
Of  the  former,  E.  coli  and  Enterobacter  spp.  are  the  most
common.  Zmistowski  et  al.26 published  a  similar  study  and
stated  that  in  the  majority  of  patients  who  presented  with
prosthetic  joint  infection  due  to  Gram-negative  bacilli  pri-
mary  urinary  infections  were  involved.  In  our  study  we
isolated  this  same  type  of  Gram-negative  bacteria.  However,
it  was  of  note  that  in  one  case  Salmonella  spp.  was  iso-
lated.  Prosthetic  joint  infections  due  to  Salmonella  spp.  are
rare  and  generally  associated  with  haematogenous  contam-
ination,  when  patients  present  with  gastrointestinal  tract
infection.27 We  were  unable  to  discover  the  origin  of  the
prosthetic  joint  infection  due  to  Salmonella  spp.  as  we  did
not  have  sufﬁcient  clinical  patient  data.
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Prosthetic  joint  infections  are  generally  due  to  bacte-
ia  and  in  very  few  cases  involve  fungal  microorganisms.
owever,  in  patients  with  chronic  prosthetic  joint  infection
ho  have  been  administered  antimicrobial  therapy  for  some
ime,  the  risk  of  the  prosthetic  joint  becoming  infected
y  fungal  microorganisms  increases.28 In  keeping  with  the
requency  of  fungal  microorganisms  in  prosthetic  joint  infec-
ion  its  isolation  has  been  reported  in  under  1%  of  cases,
andida  spp.  being  the  most  common  genus  and,  by  species,
.  albicans.29,30 The  percentage  of  fungal  microorganisms
e  isolated  was  high  compared  with  that  published  previ-
usly;  of  all  the  species  we  cultivated,  the  majority  were
ifferent  from  C.  albicans.
Anaerobic  bacteria  are  another  of  the  microorganisms
f  increased  relevance  in  prosthetic  joint  infection  over
ecent  years.  They  are  difﬁcult  to  isolate  and  identify
ecause  they  require  specialised  culture  mediums  and
engthy  incubation.31 Automated  blood  culture  systems  have
rovided  a  solution  to  this  problem.  Minassian  et  al.32 use  the
D  BACTECTM system  as  a diagnostic  prosthetic  joint  infec-
ion  tool;  in  their  study  the  authors  recuperated  a  large
umber  of  anaerobic  bacteria  through  this  system,  mainly
ropionibacterium  spp.,  a bacteria  which  is  isolated  in  a  low
ercentage  and  recognised  as  the  cause  of  prosthetic  joint
nfection.33 We  isolated  a  very  small  number  of  anaerobic
acteria,  despite  having  optimised  the  culture  conditions
o  isolate  them,  and  we  used  highly  specialised  culture
ediums  (thioglycolate  broth  and  phenyl  alcohol  agar).  To
ncrease  recuperation  of  this  type  of  microorganisms  it  was
uggested  that  molecular  biology  techniques  be  used,  such
s  the  ampliﬁcation  of  the  16S  RNA  gene,  which  has  proven
ffective  in  the  diagnosis  of  prosthetic  joint  infection.34
Indiscriminate  use  of  antibiotics  has  led  to  high  per-
entages  of  antimicrobial  resistance  in  bacteria.35 This  high
esistance  is  the  main  cause  of  prophylactic  antimicrobial
herapies  failing  to  prevent  prosthetic  joint  infection.36 In  a
ulticentre  study  published  by  Tornero  et  al.37 on  resistance
n  isolated  S.  aureus  and  S.  epidermidis  of  prosthetic  joint
nfection  between  1999  and  2009,  it  was  found  that  approx-
mately  9%  of  the  S.  aureus  were  resistant  to  meticillin,
hilst  resistance  to  these  same  antibiotics  in  S.  epidermidis
as  60%;  resistance  to  ﬂuoroquinolones  in  these  bacteria
as  16%  and  35%,  respectively.  In  our  study  we  observed
uch  higher  resistance  percentages  for  ﬂuoroquinolones  in
.  aureus  and  S.  epidermidis. In  a  similar  study,  Martínez  Pas-
or  et  al.38 described  the  resistance  in  Gram-negative  bacilli,
ainly  those  of  E.  coli, which  were  prosthetic  joint  infection
solated  between  2000  and  2007,  in  the  orthopaedic  hospi-
al  of  Spain;  in  their  results  these  authors  mention  that  85%
f  the  E.  coli  they  isolated  from  prosthetic  joint  infection
ere  producers  of  broad  spectrum  beta  lactamases  and  50%
ere  resistant  to  ﬂuoroquinolones.  The  percentage  of  E.  coli
trains  which  were  producers  of  broad  spectrum  beta  lacta-
ases  which  we  found  were  similar  to  those  documented
y  Martínez  Pastor  et  al.38 Notwithstanding,  resistance  to
uoroquinolones  was  much  higher.  Resistance  to  ampicillin
n  the  E.  faecalis  we  isolated  was  not  as  high  (21%),  which
s  striking,  as  in  recent  years  it  has  been  observed  that
linical  strains  of  E.  faecalis  isolated  in  different  types  of
nfections  show  a diminished  susceptibility  to  this  antibiotic,
nd  the  use  of  broader  spectrum  drugs  have  therefore  been
equired.39 In  general  the  differences  in  resistance  patterns
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276  
etween  the  different  microorganisms  isolated  in  prosthetic
oint  infection  are  due  to  the  clonal  selection  by  selec-
ive  pressure,  which  is  the  product  of  indiscriminate  use  of
ntibiotics  and  to  the  type  of  antimicrobial  therapies  used
n  different  geographical  areas  and  different  hospitals.40
Lastly,  the  greatest  contribution  of  this  study  is  the
etailed  analysis  of  the  microbiological  characteristics  and
ntimicrobial  resistance  patterns  which  present  in  pros-
hetic  joint  infection.  These  results  are  exponential  since
he  National  Institute  of  Rehabilitation  is  one  of  the  most
mportant  referral  centres  in  Mexico,  and  these  same  char-
cteristics  may  be  presented  in  much  smaller  centres.  A
ajor  factor  of  current  consideration  is  to  analyse  whether
he  prophylactic  antimicrobial  therapies  used  in  Mexico  to
revent  prosthetic  joint  infection  are  effective,  since  we
nd  much  greater  antimicrobial  resistance  in  microorgan-
sms  that  cause  this  type  of  infections.
onclusion
he  microbiological  characteristics  in  prosthetic  joint  infec-
ion  vary  depending  on  the  hospitals;  in  this  series  we  found
 higher  proportion  of  coagulase-negative  Staphylococci
nd  Enterococcus  spp.,  and  also  a  high  antimicrobial
esistance.
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